Doses to pelvic bone marrow from intracavitary brachytherapy in carcinoma cervix: A dosimetric study

Key Points

• To measure the doses received by pelvic bone marrow during intracavitary brachytherapy for cervical cancer.
• Conducted a dosimetric analysis of intracavitary brachytherapy treatments.
• Measured radiation doses delivered to pelvic bone marrow (PBM).
• Analyzed the percentage of PBM affected by the radiation from treatment.
• Approximately 15-20% of pelvic bone marrow receives about 1 Gy per 7 Gy fraction.
• Identified the significant contribution of ICBT to PBM radiation exposure.